Popular Allergy Medication Withdrawn Due to Potentially Fatal Risks
· Telemundo McAllen (KTLM)
The FDA has announced a voluntary recall of four lots of Cetirizine Hydrochloride tablets, commonly used for allergy relief, due to potential contamination with ranitidine. This contamination poses serious health risks, including severe allergic reactions and anaphylaxis, particularly for individuals sensitive to ranitidine. The affected lots, distributed by Rising Pharma Holdings Inc., include GY825029, GY825030, GY825031, and GY825032, with an expiration date of October 2028. Consumers are advised to check their medications and consult healthcare providers if they have concerns about possible contamination.
AI summary · Source: Telemundo McAllen (KTLM) →
